Quarterly Results • Search Archive
Anthem Biosciences Limited
Results, Financials & Updates
Follow Anthem Biosciences Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Anthem Biosciences Limited: latest results and financials
About the business in Nivata's latest coverage
Anthem Biosciences Limited is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) headquartered in Bengaluru, Karnataka. The company provides fully integrated services spanning drug discovery, development, and commercial manufacturing for both small and large molecules globally. The business operates across specialized segments, featuring integrated capabilities in New Chemical Entities (NCE) and New Biological Entities (NBE). Its operations encompass drug discovery, custom synthesis, late-stage development, and commercial production serving emerging biotech and large pharmaceutical clients worldwide.
Quarter history
Anthem Biosciences Limited Results & Financials
Latest Nivata coverage: Q1 FY27 · revenue ₹418.22 Cr · PAT ₹119.94 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.